Endovascular brachytherapy with (192)Ir and (188)Re to treat de novo and recurrent infrainguinal restenoses.
We present a review of the literature on endovascular brachytherapy (EVBT) after percutaneous transluminal angioplasty (PTA) in the femoropopliteal and tibial arteries. The pathophysiological changes induced by PTA and EVBT within the vessel wall, technical considerations regarding 192Ir and 188Re, the results of clinical trials, and the medication required before, during, and after EVBT are summarized.
Wohlgemuth
W A
WA
Department of Radiology, Klinikum Augsburg, Augsburg, Germany.
Leissner
G
G
Wengenmair
H
H
Bohndorf
K
K
Kirchhof
K
K
D000800:Angioplasty, Balloon / Q000009:adverse effects*; D001157:Arterial Occlusive Diseases / Q000532:radiotherapy / Q000628:therapy*; D001918:Brachytherapy / Q000379:methods*; D003251:Constriction, Pathologic; D006801:Humans; D007496:Iridium Radioisotopes / Q000627:therapeutic use*; D035002:Lower Extremity / Q000098:blood supply*; D011868:Radioisotopes / Q000627:therapeutic use*; D012008:Recurrence; D012211:Rhenium / Q000627:therapeutic use*; D016896:Treatment Outcome
D007496:Iridium Radioisotopes; D011868:Radioisotopes; D012211:Rhenium